Dec. 16 at 1:36 AM
$PFE $NVAX $MRNA $JNJ
Pfizer is sharing their guidance tomorrow, and I'm not really sure what to expect. Covid sales have declined, and their recent acquisitions are still getting started before they make it to market. I have a hunch it might turn into a "sell the news" scenario, regardless of whether the news is positive or negative, especially since the stock is hovering around its peak at 26.50. But if the news is bad, it could really hit the entire Covid health sector hard.